{
    "Case ID": "062490",
    "Crime_Name": [
        "Patent Infringement and Validity Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement, Patent Validity"
    ],
    "Legal_Issue": [
        "Scope of discovery in patent litigation"
    ],
    "Governing_Law": [
        "Federal Court Rules"
    ],
    "Procedural_Stage": [
        "Discovery phase"
    ],
    "Evidence_Assessment": [
        "Relevance of nearly 800 discovery questions"
    ],
    "Decision_Outcome": [
        "Apotex's discovery motion partially granted, largely dismissed"
    ],
    "Burden_of_Proof": [
        "On Apotex to justify broad discovery"
    ],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "Rule 3 of the Federal Court Rules â€“ case management and proportionality"
    ],
    "Standard_of_Review": [
        "Judicial discretion under Rule 3"
    ],
    "Procedural_Issue": [
        "Overly broad discovery requests"
    ],
    "Grounds_for_Claim": [
        "Infringement by Apotex; validity challenges by Apotex on multiple grounds"
    ],
    "Outcome_on_Merits": [
        "Limited discovery allowed; broader inquiries rejected"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Motion denied in part, costs awarded to Merck"
    ],
    "Review_Standard": [
        "Relevance and efficiency under court rules"
    ],
    "Procedural_Fairness_Assessment": [
        "Balancing fair discovery with efficient case management"
    ],
    "Key_Evidence_Considered": [
        "Categories of discovery questions related to patent 350"
    ],
    "Legal_Framework": [
        "Canadian Federal Court procedural and substantive patent law"
    ],
    "Applicant_Challenge": [
        "Apotex seeking extensive discovery on patent validity"
    ],
    "Court_Result": [
        "Restricted discovery parameters imposed"
    ],
    "Legal_Rule_Source": [
        "Federal Court Rules, Rule 3"
    ],
    "Standard_of_Proof": [
        "Preponderance of relevance and necessity"
    ],
    "Defendant_Response": [
        "Merck argued most questions were irrelevant"
    ],
    "Evidence_Type": [
        "Interrogatories, legal arguments on relevance"
    ],
    "Remedy_Requested": [
        "Broad discovery into patent validity"
    ],
    "Outcome": [
        "Partially granted, largely dismissed; costs to Merck"
    ],
    "Decision_Authority": [
        "Federal Court judge overseeing discovery"
    ],
    "Remedy_Sought": [
        "Answers to nearly 800 discovery questions"
    ],
    "Resolution_Mechanism": [
        "Court ruling on discovery motion"
    ],
    "Legal_Provision": [
        "Rule 3, Federal Court Rules"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Merck as patent holder and plaintiff"
    ],
    "Legal_Provision_Cited": [
        "Rule 3 of the Federal Court Rules"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Irrelevance, overbreadth, lack of proportionality"
    ],
    "Applicable_Process": [
        "Discovery process in federal patent litigation"
    ],
    "Outcome_of_Review": [
        "Discovery limited to relevant matters within patent 350"
    ],
    "Pending_Relief_or_Application": [
        "Discovery motion by Apotex"
    ],
    "Jurisdiction": [
        "Federal Court of Canada"
    ],
    "Governing_Rule": [
        "Rule 3, Federal Court Rules"
    ]
}